IHT Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

IHT Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-563	Closed	-$60K	–	1512
2018 Q1	$60K	Sell	563 -100	-15%	-$12.6K	0.02%	627
2017 Q4	$87K	Hold	663	–	–	0.02%	529
2017 Q3	$73K	Buy	663 +7	+1%	+$750	0.03%	416
2017 Q2	$108	Buy	656 +100	+18%	+$10.8K	0.05%	325
2017 Q1	$65K	Buy	556 +8	+1%	+$981	0.04%	368
2016 Q4	$62K	Buy	+548	New	+$66K	0.05%	346

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IHT Wealth Management's GWPH Position: Q2 2018 in Review

IHT Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2018, closing a stake of 563 shares — an estimated $60K sold.

IHT Wealth Management first reported a position in GWPH in Q4 2016 and held it in 6 quarters. The position peaked at $87K in Q4 2017. 254 funds tracked by Wall St. Rank hold GWPH as of Q2 2018.

IHT Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 563 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2018, an estimated $60K.
IHT Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 6 quarters.
IHT Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $87K in Q4 2017.
254 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.